Leonard H. Calabrese, DO, is a graduate of the Kansas City University of Medicine and Biosciences. He performed his internal medicine training at the Cleveland Clinic Foundation followed by a fellowship in rheumatic and immunologic disease. He has been on staff since 1980.
Dr. Calabrese is a professor of medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and vice chair of the Department of Rheumatic and Immunologic Diseases. He is the director of the RJ Fasenmyer Center for Clinical Immunology at the Cleveland Clinic specializing in diseases of the immune system, in particular, autoimmune and immunodeficiency. He is particularly interested in the immunologic effects of chronic viral infections including HIV and viral hepatitis, which are the subject of both his clinical care and investigation and holds a joint appointment in the Department of Infectious Diseases.
Among his many awards and honors, Dr. Calabrese has received the Phillips Medal of Public Service from the Ohio University College of Osteopathic Medicine, the Bruce Hubbard Stewart Award for humanitarianism, and holds the RJ Fasenmyer Chair of Clinical Immunology at the Cleveland Clinic Foundation.
Dr. Calabrese is also interested in medical history, medical professionalism, and the role of empathy in health care and he holds a joint appointment in the Department of Bioethics, Humanities, and Spiritual Care as well. Dr. Calabrese is a member of numerous societies including the American Osier Society.
Dr. Calabrese has lectured nationally and internationally on the subjects of clinical immunology, rheumatology, and virology and is the author of over 350 published peer reviewed articles, book chapters, and reviews.
Allan Gibofsky, MD, JD, is a professor of medicine, healthcare policy, and research at Weill Medical College of Cornell University, and an adjunct professor of law at Fordham University School of Law. He is an attending physician and rheumatologist at both New York-Presbyterian Hospital and Hospital for Special Surgery, where he is a co-director of the Inflammatory Arthritis Clinic.
Dr. Gibofsky received his undergraduate degree from Brooklyn College of the City University of New York, his medical degree from Cornell University Medical College, and his doctor of law degree from Fordham University. He completed his internship in pathology, followed by a residency in medicine at New York Hospital. He completed his fellowship in rheumatology/immunology jointly at Hospital for Special Surgery and at Rockefeller University.
Dr. Gibofsky has authored or co-authored numerous peer-reviewed papers and textbook chapters on basic and clinical aspects of the rheumatic diseases, as well as on legal aspects of medical practice, and he is a reviewer for multiple rheumatology and clinical immunology journals. He is known for his work on mechanisms of host-microbe interactions in rheumatology, and, in particular for his basic and clinical studies on rheumatic fever. Dr. Gibofsky has participated in numerous professional and public education programs, nationally and internationally.
Dr. Gibofsky served as a member and then chair of the Arthritis Advisory Committee to the US Food and Drug Administration (FDA) and continues as a special consultant to that agency. Currently secretary-treasurer of The New York Rheumatism Association, Dr. Gibofsky is past-chair of the Medical & Scientific Committee of the New York Chapter of The Arthritis Foundation and is a recipient of their Physicians’ Leadership Award. He also served as a member of the local and national Arthritis Foundation Board of Trustees, and was chair for Professional Education. Dr. Gibofsky is a Jonas Salk Scholar of the City University and an “Alumnus of the Year” of Brooklyn College. He is a past president of the American College of Legal Medicine, and is past Chair of the American Board of Legal Medicine.
Jonathan Kay, MD, received his medical degree from the University of California School of Medicine in San Francisco, CA. He then completed an internship and residency at the hospital of the University of Pennsylvania in Philadelphia, PA and fellowships in rheumatology and immunology at The Brigham and Women’s Hospital and Harvard Medical School in Boston, MA.
Dr. Kay is a professor of medicine at the University of Massachusetts Medical School and a physician at UMass Memorial Medical Center in Worcester, where he directs clinical research in the Division of Rheumatology.
Dr. Kay is a fellow of the American College of Rheumatology and of the American College of Physicians. He is an ad hoc reviewer for many journals and a member of the editorial boards of Arthritis Care & Research, Best Practice and Research Clinical Rheumatology, and the Journal of Clinical Rheumatology. Dr. Kay lectures internationally and is the author of more than 120 publications and book chapters.
Dr. Kay’s clinical interests span the spectrum of rheumatic diseases, with special interest in rheumatoid arthritis, spondyloarthropathies, and other forms of inflammatory arthritis. He was a member of the group that developed the 2010 ACR/EULAR Diagnostic and Classification Criteria for Rheumatoid Arthritis. He chairs the Rheumatology Working Group and is a member of the Internal Medicine and Musculoskeletal Topic Advisory Groups for the World Health Organization in its revision of the International
Classification of Diseases (ICD)-11.
Over the past 2 decades, his clinical research has focused on nephrogenic systemic fibrosis (formerly known as nephrogenic fibrosing dermopathy), β2-microglobulin amyloidosis, and other rheumatologic problems of patients with chronic kidney disease. He has been a principal investigator on over 50 clinical trials of novel therapies for rheumatoid arthritis, ankylosing spondylitis, gout, and osteoarthritis. Over the past several years, he has been involved in the development of biosimilars to treat rheumatic diseases.
William F.C. Rigby, MD, is Vice Chairman of Academic Affairs for the Department of Medicine, and Professor of Medicine of Microbiology and Immunology at the Geisel School of Medicine at Dartmouth-Hitchcock Medical Center in Lebanon, NH. He received his medical degree from Harvard Medical School in Boston, MA, and completed his residency and fellowship training at Mary Hitchcock Memorial Hospital in Hanover, NH. His research interests include the scientific underpinnings of the pathogenesis and treatment of rheumatoid arthritis.
Dr. Rigby has been a successful research faculty member of the Geisel Medical School and is active as a molecular/cellular/translational immunologist, clinical researcher, and board-certified rheumatologist. His experience with clinical trials prompted his concentration on biorepository development to identify biomarkers in rheumatoid arthritis and osteoarthritis. This work includes recent publications on Copy Number Variation of Complement C4 genes and CXCL13. The variability of the outcomes of pulmonary disease with defined cystic fibrosis genotypes has made him very interested in the role of the adaptive immune response in shaping clinical phenotypes.
Dr. Rigby has also authored or coauthored articles that have been published in peer-reviewed publications, such as Journal of Immunology, Journal of Rheumatology, Blood, and Arthritis Research and Treatment. He is a member of the American Association of Immunologists, American Association for the Advancement of Science, and American Society for Microbiology.
Vibeke Strand, MD, is an adjunct clinical professor in the Division of Immunology and Rheumatology at Stanford University School of Medicine. She has been a clinical rheumatologist for more than 30 years. Dr. Strand was previously in subspecialty practice and a clinical investigator in San Francisco, and senior director of clinical research at 3 pharmaceutical/biotech companies.
Since 1991, Dr. Strand has led a consulting practice offering clinical research and regulatory strategy expertise in rheumatologic diseases to pharmaceutical and biotech companies. Over the past 20 years, she has participated in the development of all of the approved biologic agents in rheumatoid arthritis and systemic lupus erythematosus.
Dr. Strand has been an invited speaker at many FDA Arthritis Advisory Committee meetings. Since 1992, she has served as a member of the Executive Organizing Committee of Outcomes in Rheumatology Clinical Trials [OMERACT] consensus conferences. Dr. Strand is on the board and medical and scientific committee of the Northern California chapter of the Arthritis Foundation, and the scientific advisory board of CORRONA. Dr. Strand has authored over 300 publications, is a fellow of the American College of Physicians and the American College of Rheumatology, and a member of the Cosmos Club.
John R. P. Tesser, MD, is Adjunct Clinical Associate Professor, College of Health Sciences; Adjunct Assistant Professor, Division of Clinical Education, Midwestern University; and a practicing rheumatologist at Arizona Arthritis and Rheumatology Associates, PC, Phoenix, Arizona. He received his his medical degree from the University of Rochester School of Medicine and Dentistry, Rochester, New York. He completed an internship and residency in internal medicine at Maricopa Medical Center, Phoenix, followed by a fellowship in rheumatology at Bowman Gray School of Medicine, Winston-Salem, North Carolina. He previously served as Chief of Rheumatology, Maricopa Medical Center.
Dr. Tesser has been principal investigator for more than 250 clinical research trials studying all forms of rheumatic diseases, with an emphasis on rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, and osteoporosis. He served as a member of the Annual Planning Committee of the American College of Rheumatology (ACR) and the Practice Improvement Program developmental team. He was an ambassador to the Within Our Reach Campaign to find a cure for rheumatoid arthritis and works with an organization to promote the performance of clinical drug trials in Russia and the former Soviet States. He also is a member of several continuing medical education groups that develop and present educational programs focused on the rheumatic diseases. He has been a recipient of the American Academy of Physician Assistants PAragon Physician-Partnership Award.
Dr. Tesser is a diplomate of the American Board of Internal Medicine, with a subspecialty in rheumatology. He is a fellow of the ACR and the American College of Physicians, as well as a member of the American Society for Bone and Mineral Research and the International Society for Clinical Densitometry.
Dr. Tesser has authored numerous articles for many peer-reviewed medical journals, including The New England Journal of Medicine, Journal of Rheumatology, and Arthritis and Rheumatism. He has been a reviewer of abstract submissions for the ACR annual meeting and for Arthritis Care and Research.
For downloadable handouts and online resources for your clinical practice, please visit: VindicoCME.com/EducationalTools
856.994.9400 | 6900 Grove Road, Building 100 | Thorofare, New Jersey 08086
A Wyanoke Group Company